Third Time Might Be a Charm for Alvotech as FDA Accepts BLA for Humira Biosimilar

The FDA on Wednesday accepted Alvotech’s Biologics License Application for AVT02, its high-concentration and interchangeable investigational biosimilar for AbbVie’s Humira (adalimumab).